Targeting EZH2 in cancer
- Journal
- Nature Medicine
In The Last Decade
doi.org/10.1038/nm.4036 →Countries where authors are citing Targeting EZH2 in cancer
This map shows the geographic impact of Targeting EZH2 in cancer. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Targeting EZH2 in cancer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Targeting EZH2 in cancer more than expected).
Fields of papers citing Targeting EZH2 in cancer
This network shows the impact of Targeting EZH2 in cancer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Targeting EZH2 in cancer.
About Targeting EZH2 in cancer
This paper, published in 2016, received 1.1k indexed citations . Written by Kimberly H. Kim and Charles W.M. Roberts covering the research area of Molecular Biology. It is primarily cited by scholars working on Molecular Biology (949 citations), Cancer Research (302 citations) and Oncology (161 citations). Published in Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1038/nm.4036.